Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
In light of the current outbreak of Ebola virus disease, there is an urgent need to develop effective therapeutics to treat Ebola infection, and drug repurposing screening is a potentially rapid approach for identifying such therapeutics. We developed a biosafety level 2 (BSL-2) 1536-well plate assa...
Main Authors: | Jennifer Kouznetsova, Wei Sun, Carles Martínez-Romero, Gregory Tawa, Paul Shinn, Catherine Z Chen, Aaron Schimmer, Philip Sanderson, John C McKew, Wei Zheng, Adolfo García-Sastre |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2014-01-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1038/emi.2014.88 |
Similar Items
-
Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity
by: Valentina Agnolon, et al.
Published: (2020-11-01) -
Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea
by: Rafael Van den Bergh, et al.
Published: (2016-02-01) -
A Systematic Review of Computational Drug Discovery, Development, and Repurposing for Ebola Virus Disease Treatment
by: James Schuler, et al.
Published: (2017-10-01) -
Symptom-Based Ebola Risk Score for Ebola Virus Disease, Conakry, Guinea
by: Brecht Ingelbeen, et al.
Published: (2018-06-01) -
Structural and Functional Aspects of Ebola Virus Proteins
by: Sahil Jain, et al.
Published: (2021-10-01)